Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
30 studies found for:    Open Studies | "Meningioma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Phase II Study Of Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas
Condition: Meningioma
Intervention: Drug: AZD2014
2 Recruiting A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma
Condition: Meningiomas
Intervention: Drug: Nivolumab
3 Not yet recruiting Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas
Condition: Meningioma
Interventions: Radiation: Radiotherapy 68 Gy(RBE);   Radiation: Radiotherapy 72 Gy(RBE);   Radiation: Radiotherapy 60 Gy(RBE)
4 Recruiting Trabectedin for Recurrent Grade II/III Meningioma
Condition: Recurrent High Grade Meningioma
Interventions: Drug: Trabectedin;   Other: Local standard of care
5 Recruiting Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas
Conditions: Recurrent Meningiomas;   Resistant Meningiomas
Interventions: Drug: Everolimus;   Drug: Octreotide
6 Recruiting Cavernous Sinus Dissection and Bleeding in Meningiomas
Condition: Meningiomas of the Middle Cranial Fossa
Intervention: Other: surgery
7 Recruiting A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
Conditions: Meningioma;   Brain Tumor
Intervention: Radiation: Intensity Modulated Proton Therapy (IMPT)
8 Recruiting Proton Radiation For Meningiomas and Hemangiopericytomas
Condition: Patients With a Diagnosis of WHO Grade I-III Meningioma and Hemangiopericytoma With Adequate Bone Marrow Function
Intervention: Radiation: Proton Radiation
9 Recruiting Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas
Conditions: Intracranial Meningioma;   Recurrent Meningioma;   NF2 Gene Mutation
Interventions: Drug: vismodegib;   Drug: GSK2256098
10 Recruiting Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
Conditions: Glioblastoma Multiforme;   Meningioma
Intervention: Drug: Ribociclib
11 Not yet recruiting A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma
Conditions: Atypical Meningioma;   Anaplastic Meningioma;   Hemangiopericytoma
Intervention: Drug: Pembrolizumab
12 Not yet recruiting Oncological Care for Patients With Meningioma
Conditions: Atypical Meningioma;   Clear-cell Meningioma;   Chordoid Meningioma;   Anaplastic Meningioma;   Rhabdoid Meningioma;   Papillary Meningioma
Intervention:
13 Not yet recruiting Effects of Scalp Nerve Blocks on Systemic Inflammation
Condition: Meningiomas
Interventions: Procedure: Scalp Nerve Blocks With Ropivacaine;   Procedure: Scalp Nerve Blocks With Saline
14 Recruiting AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Conditions: Neurofibromatosis 2;   Meningioma
Intervention: Drug: AZD2014
15 Recruiting Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Conditions: Anaplastic (Malignant) Meningioma;   Atypical Meningioma;   Grade II Meningioma;   Grade III Meningioma;   Recurrent Meningioma;   Supratentorial Meningioma
Interventions: Biological: Bevacizumab;   Procedure: Electric Field Therapy;   Device: NovoTTF-100A Device;   Procedure: Quality-of-Life Assessment
16 Recruiting Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Conditions: Neurofibromatosis Type 2;   Vestibular Schwannomas;   Meningiomas
Intervention: Drug: RAD001
17 Recruiting Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Conditions: Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
Intervention: Drug: AR-42
18 Recruiting Multisession Radiosurgery for Optic Nerve Sheath Meningiomas
Condition: Optic Nerve Sheath Tumors, Benign
Intervention: Radiation: Multisession Radiosurgery
19 Not yet recruiting Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory
Conditions: Cavernous Sinus Meningioma;   Pituitary Adenoma
Intervention: Other: Evaluation of autobiographical memory
20 Not yet recruiting Dosimetry Guided PRRT With 90Y-DOTATOC
Conditions: Neuroendrocrine Tumors;   Meningioma;   Neuroblastoma;   Medulloblastoma
Interventions: Radiation: 90Y-DOTA-3-tyr-Octreotide;   Procedure: Positron Emission Tomography (PET) whole body scan;   Drug: Amino Acids

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.